Last Updated on October 10, 2024 by The Health Master
Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited) has received final approval from the United States Food and Drug Administration (USFDA) to market Silodosin Capsules, 4 mg and 8 mg (USRLD: Rapaflo capsules).
The company also received final approval to market Pregabalin capsules, 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg, and 300 mg (USRLD: Lyrica capsules).
Silodosin capsules are indicated to treat the signs and symptoms of an enlarged prostate gland, which is also known as benign enlargement of the prostate (benign prostatic hyperplasia, or BPH).
Silodosin capsules had annual sales of USD 14 mn in the United States according to IQVIA data (IQVIA MAT Sep 2022).
Pregabalin capsules are indicated to treat pain caused by nerve damage due to diabetes or shingles (herpes zoster) infection.
It is also used to treat nerve pain caused by a spinal cord injury and pain in people with fibromyalgia.
Pregabalin capsules had annual sales of USD 242 mn in the United States according to IQVIA data (IQVIA MAT Sep 2022).
The group now has 338 approvals and has so far filed over 431* ANDAs since the commencement of the filing process in FY 2003-2004.
The group has manufacturing sites and research facilities spread across five states of Gujarat, Maharashtra, Goa, Himachal Pradesh, and Sikkim in India and in the US and Brazil.
USFDA gives final approval for Desonide cream
USFDA gives nod for Diclofenac Sodium topical solution
USFDA gives approval for Venlafaxine ER tablets
USFDA gives nod for Levothyroxine Sodium For Injection
USFDA gives nod for Nifedipine ER tablets
USFDA gives nod for Amphotericin B Liposome Injection
Parliament panel recommendation for National Commission on Medical Devices
Homoeopathy: Commission notifies BHMS Regulations 2022
USFDA gives final approval for Desonide cream
Gujarat sets up new 784 manufacturing units during the last one year
National roundtable on safe Blood Transfusions
USFDA lists Sun Pharma’s Halol unit under ‘Import Alert’
Govt soon to set up Export Promotion Council for Medical Devices
CDSCO Panel gives nod for FDC Tamsulosin + Solifenacin
IPC alert: About Norfloxacin induced skin hyperpigmentation
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
